In vitro and in vivo immunogenicity assessment of protein aggregate characteristics

MLA

Camilla Thorlaksen, et al. “In Vitro and in Vivo Immunogenicity Assessment of Protein Aggregate Characteristics.” International Journal of Pharmaceutics, vol. 631, Oct. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7b651b4412052685c98b1342884adc6f&authtype=sso&custid=ns315887.

APA

Camilla Thorlaksen, Heidi S. Schultz, Simon K. Gammelgaard, Wim Jiskoot, Nikos S. Hatzakis, Flemming S. Nielsen, Helene Solberg, Vito Foderà, Christina Bartholdy, & Minna Groenning. (2022). In vitro and in vivo immunogenicity assessment of protein aggregate characteristics. International Journal of Pharmaceutics, 631.

Chicago

Camilla Thorlaksen, Heidi S. Schultz, Simon K. Gammelgaard, Wim Jiskoot, Nikos S. Hatzakis, Flemming S. Nielsen, Helene Solberg, Vito Foderà, Christina Bartholdy, and Minna Groenning. 2022. “In Vitro and in Vivo Immunogenicity Assessment of Protein Aggregate Characteristics.” International Journal of Pharmaceutics 631 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7b651b4412052685c98b1342884adc6f&authtype=sso&custid=ns315887.